These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 392183)

  • 21. Renal osteodystrophy and its treatment.
    Duursma SA; Mees EJ
    Neth J Med; 1973; 16(2):101-7. PubMed ID: 4705764
    [No Abstract]   [Full Text] [Related]  

  • 22. Is parathyroid hormone a uremic toxin?
    Massry SG
    Nephron; 1977; 19(3):125-30. PubMed ID: 895963
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of phosphate and other factors on the pathogenesis of renal osteodystrophy.
    Slatopolsky E; Rutherford WE; Martin K; Hruska K
    Adv Exp Med Biol; 1977; 81():467-75. PubMed ID: 899937
    [No Abstract]   [Full Text] [Related]  

  • 24. Total parathyroidectomy: parathyroid hormone levels and supernumerary glands in hemodialysis patients.
    Meakins JL; Milne CA; Hollomby DJ; Goltzman D
    Clin Invest Med; 1984; 7(1):21-5. PubMed ID: 6723120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Monstrous tumourous changes of the facial bones in secondary hyperparathyroidism (author's transl)].
    Pfeifle J; Koch H; Grabensee B; Knieriem HI
    Dtsch Med Wochenschr; 1974 Mar; 99(9):389-91. PubMed ID: 4828634
    [No Abstract]   [Full Text] [Related]  

  • 26. The BSM-1 vitamin D receptor polymorphism and secondary hyperparathyroidism.
    McCarey D; Spooner R; Jagger C; McLellan AR; Jardine AG
    Nephrol Dial Transplant; 1998 Mar; 13(3):811-2. PubMed ID: 9550681
    [No Abstract]   [Full Text] [Related]  

  • 27. Calcium acetate versus calcium carbonate and erythropoietin dosages in haemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Nephrol Dial Transplant; 1995 Dec; 10(12):2321-4. PubMed ID: 8808233
    [No Abstract]   [Full Text] [Related]  

  • 28. The molecular basis of secondary hyperparathyroidism in chronic renal failure.
    Rahamimov R; Silver J
    Isr J Med Sci; 1994 Jan; 30(1):26-31. PubMed ID: 8138394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlation of serum parathyroid hormone level with other parameters of secondary hyperparathyroidism in renal insufficiency].
    Loew H; Hrubesch M; Meermann R
    Med Welt; 1976 Nov; 27(47):2272-4. PubMed ID: 1004171
    [No Abstract]   [Full Text] [Related]  

  • 30. [Laboratory diagnosis of renal diseases. Modern views on the pathogenesis of uremic osteodystrophy. I].
    Jelonek A
    Przegl Lek; 1974; 31(8):758-62. PubMed ID: 4409945
    [No Abstract]   [Full Text] [Related]  

  • 31. Secondary hyperparathyroidism is not always an obstacle to improved growth during recombinant human growth hormone treatment.
    Picca S; Perruzza I; Cappa M; Rizzoni G
    Nephron; 1997; 75(2):239-40. PubMed ID: 9041550
    [No Abstract]   [Full Text] [Related]  

  • 32. Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation.
    Lewin E; Garfia B; Recio FL; Rodriguez M; Olgaard K
    J Am Soc Nephrol; 2002 Aug; 13(8):2110-6. PubMed ID: 12138143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Secondary hyperparathyroidism in patients with chronic kidney failure].
    Fillastre JP; Robert M; Dubois D
    Sem Hop; 1973 Feb; 49(7):501-6. PubMed ID: 4350601
    [No Abstract]   [Full Text] [Related]  

  • 34. News on biomarkers in CKD-MBD.
    Mazzaferro S; Tartaglione L; Rotondi S; Bover J; Goldsmith D; Pasquali M
    Semin Nephrol; 2014 Nov; 34(6):598-611. PubMed ID: 25498379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [PTH and bone metabolism in chronic dialysis patients].
    Fukagawa M; Kazama J; Shigematsu T
    Rinsho Byori; 2001 Mar; 49(3):236-8. PubMed ID: 11307321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel mechanism for skeletal resistance in uremia.
    Slatopolsky E; Finch J; Clay P; Martin D; Sicard G; Singer G; Gao P; Cantor T; Dusso A
    Kidney Int; 2000 Aug; 58(2):753-61. PubMed ID: 10916099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parathyroid dysfunction end stage renal disease.
    DiTella PJ; Lang GR
    Otolaryngol Clin North Am; 1980 Feb; 13(1):193-201. PubMed ID: 7367004
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia.
    Rao DS; Shih MS; Mohini R
    N Engl J Med; 1993 Jan; 328(3):171-5. PubMed ID: 8417383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Renal osteodystrophy: role of vitamin D and parathyroid hormone].
    Drüeke T; Ulmann A
    Nouv Presse Med; 1979 May; 8(23):1901-3. PubMed ID: 223122
    [No Abstract]   [Full Text] [Related]  

  • 40. Surgically induced uremia in rats. I: Effect on bone strength and metabolism.
    Jablonski G; Klem KH; Attramadal A; Dahl E; Rønningen H; Gautvik KM; Haug E; Gordeladze JO
    Biosci Rep; 1993 Oct; 13(5):275-87. PubMed ID: 8142613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.